English, PDF, 539kb
Burma (also known as Myanmar) is a fragile state, one of the poorest countries in Asia, with a long history of political unrest and armed conflict. Following elections in 2010, the country is now undergoing rapid change. The UK is the largest international donor to Burma. This review assesses whether DFID is achieving impact and value for money in Burma through its aid to the health sector.
English, PDF, 842kb
The purpose of the review is to provide an independent and evidence-based assessment of the development effectiveness of WHO programs for use by external stakeholders, primarily bilateral development agencies.
English, PDF, 4,714kb
Improved outcomes for women and children as more education, lower fertility rates, higher nutritional status, and lower incidence of illness, among other outcomes, have broad benefits. After more than a decade of effort, these goals have proved difficult to attain and are unlikely to be achieved by 2015.
English, PDF, 3,488kb
Seeking to achieve a participatory approach to development has been the focus of much donor attention, as well as an expressed objective for the governments of many developing countries. The overall objective of which is to develop and pilot test a methodological framework that can be used by international development agencies to improve understanding of the importance of local ownership and participation for aid effectiveness.
English, PDF, 2,167kb
Recognizing the need for a better understanding of the impact of community responses, the World Bank and DfID launched this evaluation in 2009, using a variety of methodologies, instruments, and country settings, the portfolio of 15 studies has produced rich and illuminating results helpful to policymakers, researchers, civil society, and evaluators. This document analyzes and synthesizes the findings.
English, PDF, 2,528kb
The purpose of the Review of the Health SWAp is to assess the effectiveness of the program in supporting the implementation of the Health Sector Plan 2008-2018; the extent to which it has delivered value for money; whether the program design was appropriate to the political, policy and fiscal context; and whether it has laid a foundation for future donor engagement.
English, PDF, 534kb
This paper presents evidence collected during the expansion of the SKY Health Microinsurance program in rural Cambodia. Health insurance is a newer product in developing countries, and this type of evidence has rarely been explored.
English, PDF, 1,078kb
The US$136 million, multi-donor, Three Diseases Fund (3DF) (2006-2011) was established to reduce the burden of communicable disease mortality and morbidity for HIV/AIDS, Tuberculosis (TB) and malaria in Myanmar. The final evaluation of the 3DF aimed to document lessons learnt to inform future health funding and the evaluation of the Three Millennium Development Goal (3MDG) Fund.
English, PDF, 591kb
Results of empirical studies of the importance of adverse selection remain mixed. In addition, in many empirical studies the effects of adverse selection are difficult to disentangle from the effects of moral hazard.
English, PDF, 1,760kb
The New Zealand Ministry of Foreign Affairs and Trade has provided funding to the Leprosy Mission of New Zealand to support health initiatives at community level in Bougainville, an autonomous province of Papua New Guinea. Funding has been provided since 2005, with a new model commencing in 2009. This independent evaluation assessed the overall performance of the Bougainville Healthy Communities Programme since 2009.